These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10147035)

  • 1. Economic evaluation of pharmaceuticals: science or marketing?
    Drummond MF
    Pharmacoeconomics; 1992 Jan; 1(1):8-13. PubMed ID: 10147035
    [No Abstract]   [Full Text] [Related]  

  • 2. A reappraisal of economic evaluation of pharmaceuticals. Science or marketing?
    Drummond MF
    Pharmacoeconomics; 1998 Jul; 14(1):1-9. PubMed ID: 10182189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmaceuticals and medical devices: business practices. Issue brief.
    Thomson Reuters/West
    Issue Brief Health Policy Track Serv; 2011 Jan; ():1-44. PubMed ID: 21374840
    [No Abstract]   [Full Text] [Related]  

  • 4. Economic evaluation of pharmaceuticals. Frankenstein's monster or vampire of trials?
    O'Brien B
    Med Care; 1996 Dec; 34(12 Suppl):DS99-108. PubMed ID: 8969318
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluating the quality of published pharmacoeconomic evaluations.
    Sanchez LA
    Hosp Pharm; 1995 Feb; 30(2):146-8, 151-2. PubMed ID: 10140528
    [No Abstract]   [Full Text] [Related]  

  • 6. Cost-effectiveness analysis: obstacles to standardisation and its use in regulating pharmaceuticals.
    Luce BR
    Pharmacoeconomics; 1993 Jan; 3(1):1-9. PubMed ID: 10146982
    [No Abstract]   [Full Text] [Related]  

  • 7. MaLAM, a medical lobby for appropriate marketing of pharmaceuticals.
    Mansfield PR
    Med J Aust; 1997 Dec 1-15; 167(11-12):590-2. PubMed ID: 9418797
    [No Abstract]   [Full Text] [Related]  

  • 8. [The Israeli pharmaceutical market].
    Shani S; Shemer J
    Harefuah; 1999 Jul; 137(1-2):1-4, 88. PubMed ID: 10959264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacoeconomics: an emerging discipline.
    Letizia C
    Qual Assur; 1995 Mar; 4(1):68-74. PubMed ID: 8520866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transparency in economic evaluations.
    Hill S
    Pharmacoeconomics; 2005; 23(10):967-9. PubMed ID: 16235971
    [No Abstract]   [Full Text] [Related]  

  • 11. Eliminate the middleman.
    Blaivas JG
    Neurourol Urodyn; 1998; 17(3):157-8. PubMed ID: 9590468
    [No Abstract]   [Full Text] [Related]  

  • 12. The political economy of pharmaceutical marketing channels: a conceptual framework.
    Doucette WR; Schommer JC; Wiederholt JB
    Clin Ther; 1993; 15(4):739-51. PubMed ID: 8221824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesizing evidence from multiple studies. The role of meta-analysis in pharmacoeconomics.
    Lafata JE; Koch GG; Ward RE
    Med Care; 1996 Dec; 34(12 Suppl):DS136-45. PubMed ID: 8969322
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacists' and physicians' attitudes toward pharmaceutical marketing practices.
    Poirier TI; Giannetti V; Giudici RA
    Am J Hosp Pharm; 1994 Feb; 51(3):378-81. PubMed ID: 8160692
    [No Abstract]   [Full Text] [Related]  

  • 15. Working toward a common currency: is standardization of cost-effectiveness analysis possible?
    Luce BR
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 4():S19-22. PubMed ID: 7493194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Researching the market: initial steps in designing a marketing program.
    Tootelian DH
    Am Pharm; 1990 Jan; NS30(1):23-8. PubMed ID: 2301248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there a need for standardization of methods in economic evaluations of medicine?
    Rittenhouse BE
    Med Care; 1996 Dec; 34(12 Suppl):DS13-22. PubMed ID: 8969311
    [No Abstract]   [Full Text] [Related]  

  • 18. Methodological and conduct principles for pharmacoeconomic research. Pharmaceutical Research and Manufacturers of America.
    Clemens K; Townsend R; Luscombe F; Mauskopf J; Osterhaus J; Bobula J
    Pharmacoeconomics; 1995 Aug; 8(2):169-74. PubMed ID: 10155611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The revised Canadian Guidelines for the Economic Evaluation of Pharmaceuticals.
    Glennie JL; Torrance GW; Baladi JF; Berka C; Hubbard E; Menon D; Otten N; Rivière M
    Pharmacoeconomics; 1999 May; 15(5):459-68. PubMed ID: 10537963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Avoiding legal and ethical pitfalls of industry-sponsored research: the co-existence of research, scholarship, and marketing in the pharmaceutical industry.
    Dorfman HL; Reig LP
    Food Drug Law J; 2004; 59(4):595-615. PubMed ID: 15880876
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.